Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$643M |
| 2 |
AT&T
T
|
+$311M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$306M |
| 4 |
Microsoft
MSFT
|
+$292M |
| 5 |
Ametek
AME
|
+$215M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$887M |
| 2 |
Apple
AAPL
|
+$694M |
| 3 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$616M |
| 4 |
Amazon
AMZN
|
+$596M |
| 5 |
Linde
LIN
|
+$531M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.39% |
| 2 | Financials | 6.67% |
| 3 | Healthcare | 6.18% |
| 4 | Industrials | 4.97% |
| 5 | Consumer Discretionary | 4.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3501
Gyre Therapeutics
GYRE
$671M
| $2.76M | ﹤0.01% |
89,497
-15,536
| -15% | -$511K |
|
|
NUAN
3502
CALL
DELISTED
Nuance Communications, Inc.
NUAN
| $2.76M | ﹤0.01% |
50,100
-44,200
| -47% | -$2.43M |
|
3503
Ball Corp
BALL
$17.3B
| $2.76M | ﹤0.01% |
30,629
-537,100
| -95% | -$47.6M |
|
3504
Healthpeak Properties
DOC
$15B
| $2.75M | ﹤0.01% |
82,250
+10,363
| +14% | +$367K |
|
3505
Sensata Technologies
ST
$6.78B
| $2.75M | ﹤0.01% |
50,284
-154,007
| -75% | -$8.85M |
|
3506
Enpro
NPO
$6.83B
| $2.75M | ﹤0.01% |
31,555
-11,124
| -26% | -$977K |
|
|
TRTX
3507
TPG RE Finance Trust
TRTX
$616M
| $2.75M | ﹤0.01% |
221,925
-62,009
| -22% | -$794K |
|
|
AMRS
3508
CALL
DELISTED
Amyris Inc.
AMRS
| $2.75M | ﹤0.01% |
+200,000
| New | +$2.86M |
|
3509
Shattuck Labs
STTK
$681M
| $2.74M | ﹤0.01% |
+134,532
| New | +$2.88M |
|
3510
Arbor Realty Trust
ABR
$981M
| $2.74M | ﹤0.01% |
147,874
-200,467
| -58% | -$3.62M |
|
3511
PUT
GameStop
GME
$8.42B
| $2.74M | ﹤0.01% |
62,400
-138,800
| -69% | -$6.34M |
|
|
KRTX
3512
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $2.73M | ﹤0.01% |
+22,348
| New | +$2.58M |
|
|
KNTE
3513
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
| $2.73M | ﹤0.01% |
+118,734
| New | +$2.58M |
|
3514
CALL
Vornado Realty Trust
VNO
$7.5B
| $2.73M | ﹤0.01% |
+65,000
| New | +$2.8M |
|
3515
Lloyds Banking Group
LYG
$90.1B
| $2.73M | ﹤0.01% |
1,113,838
-2,333,536
| -68% | -$5.72M |
|
|
FZT
3516
DELISTED
FAST Acquisition Corp. II
FZT
| $2.73M | ﹤0.01% |
280,999
-331,048
| -54% | -$3.22M |
|
|
HT
3517
DELISTED
Hersha Hospitality Trust Priority Class A Common Shares of Beneficial Interest
HT
| $2.72M | ﹤0.01% |
291,976
+187,291
| +179% | +$1.78M |
|
|
KIII
3518
DELISTED
Kismet Acquisition Three Corp. Class A Ordinary Shares
KIII
| $2.72M | ﹤0.01% |
279,934
+95,744
| +52% | +$925K |
|
|
XHR
3519
Xenia Hotels & Resorts
XHR
$1.89B
| $2.72M | ﹤0.01% |
153,516
-105,586
| -41% | -$1.85M |
|
3520
PUT
KE Holdings
BEKE
$19B
| $2.72M | ﹤0.01% |
149,000
-7,400
| -5% | -$180K |
|
3521
Pharvaris
PHVS
$2.25B
| $2.72M | ﹤0.01% |
157,753
-39,214
| -20% | -$671K |
|
|
FTH
3522
Faeth Therapeutics
FTH
$664M
| $2.72M | ﹤0.01% |
+12,933
| New | +$2.35M |
|
|
GCAC
3523
DELISTED
Growth Capital Acquisition Corp. Class A Common Stock
GCAC
| $2.72M | ﹤0.01% |
275,366
+238,652
| +650% | +$2.35M |
|
3524
Vanguard Short-Term Inflation-Protected Securities Index Fund
VTIP
$19.1B
| $2.72M | ﹤0.01% |
51,724
-7,678
| -13% | -$403K |
|
|
VEEA
3525
Veea Inc
VEEA
$8.92M
| $2.72M | ﹤0.01% |
281,094
-46,338
| -14% | -$451K |
|
Similar funds
Millennium Management's Q3 2021 Portfolio in Review
As of Q3 2021, Millennium Management held 7,698 positions worth $167B, up 2.3% from $163B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Millennium Management deployed $8.65B of net new capital in Q3 2021, opening 1,244 new positions and adding to 2,720 existing holdings. Its largest new stake was Sight Sciences: 1,577,092 shares worth $35.8M.
By sector, the portfolio is most concentrated in Technology at 7.4% of assets, down from 7.8% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Apple, an estimated $694M trimmed.
- Millennium Management's largest Q3 2021 buy was Sight Sciences: 1,577,092 shares worth $35.8M.
- Millennium Management added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $643M increase.
- Millennium Management's biggest Q3 2021 reduction was Apple, cutting an estimated $694M.
- Millennium Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $887M.
- Millennium Management's ten largest holdings make up 18% of its $167B portfolio in Q3 2021.
- Millennium Management opened 1,244 new positions and closed 981 in Q3 2021.
- Millennium Management's portfolio value rose 2.3% quarter-over-quarter to $167B.
Based on Millennium Management's 13F filing for Q3 2021, filed 15 Nov 2021.